Articles written by Nabaparna Bhattacharya - Benzinga

Rogers Communications Q4 Earnings Beat Expectations, Expects Upto 3% EBITDA Growth In 2025 (CORRECTED)

|Rogers Communications Q4 earnings miss expectations with lower-than-expected sales, but sees growth in wireless and media revenues.

MSCI Management Is Conservative, Analyst Sees Strong Momentum In 2025

|MSCI faces short-term challenges, but analyst expects solid growth in 2025 with accelerating subscription growth and strong retention rates.

Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion

|Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Roper Technologies Q4 Earnings Beat, Surpasses $2 Billion Cash Flow Milestone

|Roper Technologies Q4 earnings beat expectations, with a 16% revenue increase and $2.3 billion in free cash flow, surpassing a key milestone.

What's Going On With Mullen Automotive Stock Today?

|Mullen Automotive strengthens U.S. battery production with new equipment from Nikola.

ChargePoint Partners With AAA Clubs To Expand EV Charging: Details

|ChargePoint's stock rises following a new partnership with AAA to provide discounted EV charging services to over 12,000 service providers.

Altria Q4 Earnings Exceed Expectations, Announces $1 Billion Buyback

|Altria's Q4 earnings matched expectations, with a $1 billion share buyback authorized and strong sales growth, while projecting modest 2025 EPS growth of 2-5%.

Thermo Fisher Q4 Earnings Beat Estimates, Margin Expands

|Thermo Fisher Scientific (TMO) reports Q4 earnings of $6.10 per share, exceeding expectations. Operating income and revenue growth also increased.

Tractor Supply Q4 Earnings Miss Estimates, Stock Falls: CEO Expects 'Macro Headwinds To Abate'

|Tractor Supply Q4 Earnings Miss Estimates, Stock Drops 4.62% Despite Sales Growth and New Store Openings.

RTX's Strong Backlog And Pricing Power Offset Defense Risks, Analysts Forecast Big 2025 Upside

|RTX reports strong Q4 growth, with analysts bullish on 2025 due to strong demand, defense opportunities, and improved margins.

What's In The Cards For Walmart This Earnings Season?

|Goldman Sachs reiterates Buy on Walmart with a $101 target, citing strong earnings growth, automation benefits, and upcoming strategic meetings.

General Motors' Turnaround On Track Despite EV Roadblocks – Analysts Say

|GM reports strong Q4 earnings despite EV hurdles; analysts remain optimistic about long-term growth and turnaround potential.

Boeing's Q4 Big Miss: Earnings Plunge, But Analysts See Potential For 2025 Rebound

|Boeing's Q4 earnings miss, but analysts remain optimistic about a 2025 rebound with improved production and strong demand.

Flex Beats Q3 Earnings On Strong Sales, Margins; Stock Gains

|Flex Ltd. beats Q3 earnings expectations with strong sales and margins, raising its FY25 outlook and driving stock gains.

Scotts Miracle-Gro Q1 Earnings Beat Estimates Amid Stronger Consumer Engagement And Fall Sales

|Scotts Miracle-Gro Q1 earnings beat estimates with narrower losses, strong consumer engagement, and robust fall sales.

Coinbase Shares Trade Relatively Flat Wednesday, Platform To Launch In Argentina

|Coinbase Global shares are trading relatively flat in the premarket session on Wednesday.

Brinker Q2 Earnings Beat Estimates On Strong Chili's Sales Growth And Increased Traffic

|Brinker International's Q2 earnings beat estimates, fueled by strong Chili's sales growth, increased traffic, and higher operating margins.

Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag

|Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in biotechnology and life sciences.

DeepSeek News Plunges IT Hardware Stocks, But Analyst Sees 5 Bright Spots Among Tech Giants

|IT hardware stocks dip after DeepSeek news, but analyst sees growth potential in Corning, Hewlett Packard Enterprise, Western Digital, Seagate Technology and Apple due to specific catalysts.

Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data

|Piper Sandler analyst maintains an Overweight rating on Teva, citing positive feedback on duvakitug's potential in treating IBD.